<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2111">
  <stage>Registered</stage>
  <submitdate>21/09/2008</submitdate>
  <approvaldate>21/09/2008</approvaldate>
  <nctid>NCT00757406</nctid>
  <trial_identification>
    <studytitle>Assessment of Unilateral Lymphoedema of the Leg</studytitle>
    <scientifictitle>Assessment of Unilateral Lymphoedema of the Leg</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>UQLDEX02</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lymphedema</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1 - Test group - Lymphedema sufferers

2 - Control group - healthy volunteers

</interventions>
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>That the L-Dex U400 detects Unilateral leg lymphedema in subjects with the condition and does not detect it in subjects without the condition.</outcome>
      <timepoint>6 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Group 1:

          -  Be between the ages of 18-75 years.

          -  Self-describe general health as satisfactory.

          -  Understand the proposed study and be willing and fully able to comply with the study
             procedures.

          -  Be a willing participant and be capable of giving and has given informed written
             consent for entry into the study.

          -  Have been previously diagnosed, by current clinical practice, as having unilateral
             Lymphoedema of the leg.

        Group 2:

          -  Be between the ages of 18-75 years.

          -  Self-describe general health as satisfactory.

          -  Understand the proposed study and be willing and fully able to comply with the study
             procedures.

          -  Be a willing participant and be capable of giving and has given informed written
             consent for entry into the study.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  Have a known heart condition or an implantable device such as a pacemaker or ICD.

          -  Have a metallic surgical implant (e.g. total hip replacement) not including small
             implants such as sternal wires or surgical staples.

          -  Suffer from a renal disorder.

          -  Be taking diuretic medications.

          -  Have consumed large amounts of alcohol or caffeinated beverages within six hours of
             the study.

          -  Have undertaken excessive exercise within two hours of BIA

          -  Have a reported fever of &gt; 38Â°C at time of screening.

          -  Be currently in the fourth week of the menstrual cycle.

          -  Be pregnant or currently breastfeeding.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration>Cross-sectional</duration>
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/01/2009</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Qld Lymphoedema and Breast Oncology Physiotherapy - Brisbane</hospital>
    <postcode>4051 - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>ImpediMed Limited</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To demonstrate that ImpediMed L-Dex U400 can be used to assess unilateral Lymphoedema of the
      leg using the same principles for arms.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00757406</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Robyn C Box, PhD</name>
      <address>Qld Lymphoedema and Breast Oncology Physiotherapy</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>